Ralf-Dieter Hofheinz, Dirk Arnold, Markus Borner, Wolfgang Eisterer, Gunnar Folprecht, Michael Ghadimi, Ullrich Graeven, Birgit Grünberger, Holger Hebart, Susanna Hegewisch-Becker, Volker Heinemann, Ron Pritzkuleit, Claus Rödel, Holger Rumpold, Tanja Trarbach, Bernhard Wörmann
This article briefly summarizes clinically relevant new aspects of the recently published German, Austrian and Swiss onkopedia guideline for the treatment of locally advanced rectal cancer. Main aspects comprise (i) the use of total neoadjuvant therapy (TNT) for rectal cancers with high risk features, (ii) treatment with neoadjuvant chemotherapy for patient with a low risk for local recurrence, (iii) immunotherapy using dostarlimab in patients with MSI high /dMMR rectal cancer as well as (iv) intended organ preservation as a treatment goal...
September 17, 2024: Oncology Research and Treatment